Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 8.225 GBX 2.81%
Market Cap: 15.9m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Net Margin
Abingdon Health PLC

-41.8%
Current
-328%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-41.8%
=
Net Income
-2.2m
/
Revenue
5.3m

Net Margin Across Competitors

Country UK
Market Cap 16.3m GBP
Net Margin
-42%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.9B CHF
Net Margin
12%
Country DK
Market Cap 178.7B DKK
Net Margin
19%
Country US
Market Cap 16.1B USD
Net Margin
11%
Country KR
Market Cap 10.3T KRW
Net Margin
-358%
Country CN
Market Cap 49B CNY
Net Margin
42%
Country US
Market Cap 6.5B USD
Net Margin
29%
Country CA
Market Cap 6.4B USD
Net Margin
-8%
Country US
Market Cap 5.7B USD
Net Margin
9%
Country UK
Market Cap 4.6B GBP
Net Margin
7%
No Stocks Found

Abingdon Health PLC
Glance View

Market Cap
15.9m GBX
Industry
Health Care

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

ABDX Intrinsic Value
11.84 GBX
Undervaluation 31%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-41.8%
=
Net Income
-2.2m
/
Revenue
5.3m
What is the Net Margin of Abingdon Health PLC?

Based on Abingdon Health PLC's most recent financial statements, the company has Net Margin of -41.8%.